Skip to main content

Tower Research Capital LLC (TRC)

Position in NVO — Novo Nordisk A S

CIK 1533421 NEW YORK, NY

Position in NVO

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$15,058,240
+$13,881,726 QoQ
Shares Held
314,106
+881.2% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#123
of 1,348 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $110,167,581 across 17 Drug Manufacturers - General names. NVO ranks #3 (13.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NVO
Novo Nordisk A S
This page
314,106 $15,058,240

All Filings in NVO

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,058,240 314,106
2026-03-31 $1,176,514 32,014
2025-09-30 $98,050 1,767
2025-06-30 $9,886,492 143,241
2025-03-31 $604,752 8,709
2024-12-31 $1,085,657 12,621
2024-09-30 $1,182,722 9,933
2024-06-30 $2,429,719 17,022
2024-03-31 $1,150,720 8,962
2023-12-31 $409,351 3,957
2023-09-30 $187,062 2,057
2023-06-30 $293,721 1,815
2023-03-31 $31,668 199
2022-12-31 $10,150 75
2022-09-30 $787,674 7,906
2022-06-30 $453,297 4,068
2022-03-31 $398,669 3,590
2021-12-31 $1,044,736 9,328
2021-09-30 $3,168 33
2021-03-31 $379,574 5,630
2020-12-31 $267,455 3,829
2020-09-30 $290,633 4,186
2020-06-30 $13,750 210
2020-03-31 $13,846 230